We are part of the VISICORT project

VISICORT – Improving the Success Rate of Corneal Transplants

Adverse immune responses occur in up to 30% of corneal transplant (CT) recipients causing rejection and failure.

 Fios is part of VISICORT, an EU-funded, multi-disciplinary project with expertise in basic immunology, bio-sampling, systems biology/immune profiling, bioinformatics, clinical tissue transplantation and cell therapy.

Clinical data and bio-specimens from over 700 CT recipients at 5 leading transplant centres will be centrally collated and distributed to university- and SME-based laboratories for multi-platform profiling and integrated bioinformatics analyses.

Profiling data will generate a better understanding of adverse immune reactions to tissue transplants. This knowledge will be used to develop novel biomarker-based surveillance strategies and, coupled with SME-based expertise in cell product development, will also inform the design and initiation of an optimised clinical trial strategy of immunomodulatory stromal stem cell therapy in high-risk human CT recipients. VISICORT research will strongly impact multiple EU research/scientific communities, patient cohorts and SMEs.

Click here for more information.

Learn about Fios Genomic’s involvement in VISICORT: http://visicort.eu/partners/fios-genomics-limited/